127 related articles for article (PubMed ID: 7765352)
1. Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains.
Dorai H; McCartney JE; Hudziak RM; Tai MS; Laminet AA; Houston LL; Huston JS; Oppermann H
Biotechnology (N Y); 1994 Sep; 12(9):890-7. PubMed ID: 7765352
[TBL] [Abstract][Full Text] [Related]
2. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
[TBL] [Abstract][Full Text] [Related]
3. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression, and purification of an anti-desipramine single chain antibody in NS/O myeloma cells.
Kitchin K; Lin G; Shelver WL; Murtaugh MP; Pentel PR; Pond SM; Oberst JC; Humphrey JE; Smith JM; Flickinger MC
J Pharm Sci; 1995 Oct; 84(10):1184-9. PubMed ID: 8801332
[TBL] [Abstract][Full Text] [Related]
5. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.
Adams GP; McCartney JE; Tai MS; Oppermann H; Huston JS; Stafford WF; Bookman MA; Fand I; Houston LL; Weiner LM
Cancer Res; 1993 Sep; 53(17):4026-34. PubMed ID: 7689421
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product.
Ishida T; Tsujisaki M; Hinoda Y; Imai K; Yachi A
Jpn J Cancer Res; 1994 Feb; 85(2):172-8. PubMed ID: 7908285
[TBL] [Abstract][Full Text] [Related]
7. Medical applications of single-chain antibodies.
Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
[TBL] [Abstract][Full Text] [Related]
8. Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.
Adams GP; Tai MS; McCartney JE; Marks JD; Stafford WF; Houston LL; Huston JS; Weiner LM
Clin Cancer Res; 2006 Mar; 12(5):1599-605. PubMed ID: 16533787
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.
Schier R; Marks JD; Wolf EJ; Apell G; Wong C; McCartney JE; Bookman MA; Huston JS; Houston LL; Weiner LM
Immunotechnology; 1995 May; 1(1):73-81. PubMed ID: 9373335
[TBL] [Abstract][Full Text] [Related]
10. A plasmid system for high-level expression and in vitro processing of recombinant proteins.
Pohlner J; Krämer J; Meyer TF
Gene; 1993 Aug; 130(1):121-6. PubMed ID: 8344518
[TBL] [Abstract][Full Text] [Related]
11. Expression of Human VH Single Domains as Fc Fusions in Mammalian Cells.
Abdelatti M; Schofield P; Christ D
Methods Mol Biol; 2019; 1953():121-136. PubMed ID: 30912019
[TBL] [Abstract][Full Text] [Related]
12. Expression of recombinant Lym-1 single-chain Fv in Escherichia coli.
Bin Song K; Won M; Meares CF
Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():163-7. PubMed ID: 9756467
[TBL] [Abstract][Full Text] [Related]
13. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
[TBL] [Abstract][Full Text] [Related]
14. Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers.
Tai MS; McCartney JE; Adams GP; Jin D; Hudziak RM; Oppermann H; Laminet AA; Bookman MA; Wolf EJ; Liu S
Cancer Res; 1995 Dec; 55(23 Suppl):5983s-5989s. PubMed ID: 7493381
[TBL] [Abstract][Full Text] [Related]
15. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
[TBL] [Abstract][Full Text] [Related]
16. Antigen mimicry by an anti-idiotypic antibody single chain variable fragment.
Tripathi PK; Qin H; Deng S; Xu C; Bhattacharya-Chatterjee M; Foon KA; Chatterjee SK
Mol Immunol; 1998 Sep; 35(13):853-63. PubMed ID: 9839554
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of single-chain Fv proteins.
Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
[TBL] [Abstract][Full Text] [Related]
18. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
[TBL] [Abstract][Full Text] [Related]
19. Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Tai MS; Huston JS; Stafford WF; Bookman MA; Houston LL; Weiner LM
Cancer Immunol Immunother; 1995 May; 40(5):299-306. PubMed ID: 7600561
[TBL] [Abstract][Full Text] [Related]
20. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A.
Ito W; Kurosawa Y
J Biol Chem; 1993 Sep; 268(27):20668-75. PubMed ID: 8376416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
